tetano
Editor, Senior Moderator
Influenza Other Respir Viruses
. 2020 Oct 12.
doi: 10.1111/irv.12808. Online ahead of print.
Costs of a clinical pathway with point-of-care testing during influenza epidemic in a Dutch hospital
Sierk D Marbus[SUP] 1 [/SUP], Suzanne P M Lutgens[SUP] 2 [/SUP], Arianne B van Gageldonk-Lafeber[SUP] 1 [/SUP], Eric H L C M Hazenberg[SUP] 2 [/SUP], Mirjam H A Hermans[SUP] 2 [/SUP], Anita W M Suijkerbuijk[SUP] 1 [/SUP]
Affiliations
Abstract
Our study aim was to determine how a new clinical pathway, including PCR-based influenza point-of-care test (POCT), influences the hospitalisation costs of patients suspected of influenza presenting at the emergency department of a Dutch hospital during two consecutive influenza epidemics (2016-2017 and 2017-2018). Compared to mean costs per patient of €3661 in 2016-2017, the implementation of this new clinical pathway with influenza POCT in 2017 was associated with mean costs per influenza-positive patient of €2495 in 2017-2018 (P = .3). Our study suggests favourable economic results regarding a new clinical pathway with influenza POCT, reflecting a more efficient care of patients suspected of influenza presenting at the emergency department.
Keywords: clinical pathway; hospitalisation costs; influenza; point-of-care testing.
. 2020 Oct 12.
doi: 10.1111/irv.12808. Online ahead of print.
Costs of a clinical pathway with point-of-care testing during influenza epidemic in a Dutch hospital
Sierk D Marbus[SUP] 1 [/SUP], Suzanne P M Lutgens[SUP] 2 [/SUP], Arianne B van Gageldonk-Lafeber[SUP] 1 [/SUP], Eric H L C M Hazenberg[SUP] 2 [/SUP], Mirjam H A Hermans[SUP] 2 [/SUP], Anita W M Suijkerbuijk[SUP] 1 [/SUP]
Affiliations
- PMID: 33047471
- DOI: 10.1111/irv.12808
Abstract
Our study aim was to determine how a new clinical pathway, including PCR-based influenza point-of-care test (POCT), influences the hospitalisation costs of patients suspected of influenza presenting at the emergency department of a Dutch hospital during two consecutive influenza epidemics (2016-2017 and 2017-2018). Compared to mean costs per patient of €3661 in 2016-2017, the implementation of this new clinical pathway with influenza POCT in 2017 was associated with mean costs per influenza-positive patient of €2495 in 2017-2018 (P = .3). Our study suggests favourable economic results regarding a new clinical pathway with influenza POCT, reflecting a more efficient care of patients suspected of influenza presenting at the emergency department.
Keywords: clinical pathway; hospitalisation costs; influenza; point-of-care testing.